Christopher Michael Waggoner, | |
1924 Alcoa Hwy # U56, Knoxville, TN 37920-1511 | |
(865) 305-9081 | |
(865) 305-8769 |
Full Name | Christopher Michael Waggoner |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 8 Years |
Location | 1924 Alcoa Hwy # U56, Knoxville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780038521 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 3725 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Tn Medical Center | Knoxville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Health System, Inc. | 5294646378 | 526 |
News Archive
Nearly half of all patients with amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disorder, develop cognitive problems that affect memory and thinking.
This is a new research centre led by the University of Limerick that supports the pharmaceutical sector in Ireland. The centre will carry out research on the key aspects of what it takes to synthesise the pharmaceutically active molecule to isolate a pure material and to formulate this into a medicine.
Weill Cornell Medical College has been awarded three new research grants from the Leukemia & Lymphoma Society totaling $1.8 million. The funds will support critically-needed translational research for blood cancers, accelerating promising discoveries from the laboratory to the patient's bedside.
With the current outbreak of influenza-like illnesses, many people are trying to boost their immune systems with supplements. Ginseng is often a key ingredient, but its therapeutic use may extend far beyond that. Researchers are now investigating whether ginseng can help relieve health problems ranging from diabetes to depression to erectile dysfunction.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
› Verified 4 days ago
Entity Name | University Health System, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
Nearly half of all patients with amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disorder, develop cognitive problems that affect memory and thinking.
This is a new research centre led by the University of Limerick that supports the pharmaceutical sector in Ireland. The centre will carry out research on the key aspects of what it takes to synthesise the pharmaceutically active molecule to isolate a pure material and to formulate this into a medicine.
Weill Cornell Medical College has been awarded three new research grants from the Leukemia & Lymphoma Society totaling $1.8 million. The funds will support critically-needed translational research for blood cancers, accelerating promising discoveries from the laboratory to the patient's bedside.
With the current outbreak of influenza-like illnesses, many people are trying to boost their immune systems with supplements. Ginseng is often a key ingredient, but its therapeutic use may extend far beyond that. Researchers are now investigating whether ginseng can help relieve health problems ranging from diabetes to depression to erectile dysfunction.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Christopher Michael Waggoner, Po Box 440426, Po Box 415000-msc8135, Nashville, TN 37241-8135 Ph: (865) 670-6199 | Christopher Michael Waggoner, 1924 Alcoa Hwy # U56, Knoxville, TN 37920-1511 Ph: (865) 305-9081 |
News Archive
Nearly half of all patients with amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disorder, develop cognitive problems that affect memory and thinking.
This is a new research centre led by the University of Limerick that supports the pharmaceutical sector in Ireland. The centre will carry out research on the key aspects of what it takes to synthesise the pharmaceutically active molecule to isolate a pure material and to formulate this into a medicine.
Weill Cornell Medical College has been awarded three new research grants from the Leukemia & Lymphoma Society totaling $1.8 million. The funds will support critically-needed translational research for blood cancers, accelerating promising discoveries from the laboratory to the patient's bedside.
With the current outbreak of influenza-like illnesses, many people are trying to boost their immune systems with supplements. Ginseng is often a key ingredient, but its therapeutic use may extend far beyond that. Researchers are now investigating whether ginseng can help relieve health problems ranging from diabetes to depression to erectile dysfunction.
QRxPharma announced today the release of additional pivotal Phase 3 trial data for MoxDuo IR, an immediate-release Dual-Opioid pain therapy. Required for New Drug Application submission with the United States Food and Drug Administration, this "combination rule" study compared the efficacy and safety profiles of MoxDuo IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery.
› Verified 4 days ago
Daniel Eugene Brewer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Ryan Douglas Kerr, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Landy M Morales, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, Box 56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Sahar M Lotfi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Clayton Devereau Humphrey, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy # U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Dr. Christopher Hill, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy # U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 | |
Murad Salaita, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1924 Alcoa Hwy, U56, Knoxville, TN 37920 Phone: 865-305-9081 Fax: 865-305-8769 |